Skip Navigation

Regimen Information

For Paraplatin + Taxol + Avastin, including Side Effects

Paraplatin + Taxol + Avastin

Drugs in this Regimen:

For the treatment of Non-Small Cell Lung Cancer

How Paraplatin + Taxol + Avastin chemotherapy is given and possible side effects.

Paraplatin + Taxol + Avastin for the treatment of Non-Small Cell Lung Cancer

Paraplatin + Taxol + Avastin is a chemotherapy and biologic regimen used in the treatment of non-small cell lung cancer. This treatment involves three drugs: Paraplatin (carboplatin), Taxol (paclitaxel) and Avastin (bevacizumab).

Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.


  • Anemia

  • Nausea & Vomiting

  • Appetite Loss

  • Risk of Infection

For more information, see the 'Expert Resources' tab below.

Community Responses

Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.

What side effects did you experience while on this medication?

Hi, I'm Janaye

Mostly my symptoms were severe fatigue and bone pain. I managed them by staying in bed, indulging myself a bit and use of hydrocodon.

  • Mon Sep 1, 2014

This discussion needs your voice!

What were the specific side effects that you experienced while taking this medication? How did you manage them?

What coping tips would you give to new patients on this regimen?

There are currently no answers to this question. Be the first to answer!

This discussion needs your voice!

What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?

Treatment Overview

This chemotherapy regimen is commonly used to treat:

See Expert Resources

The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the the National Cancer Institute and other experts.